doi: 10.1177/003335490712200613.
A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac initiative
Affiliations
- PMID: 18051674
- PMCID: PMC1997250
- DOI: 10.1177/003335490712200613
Item in Clipboard
A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac initiative
Public Health Rep.
2007 Nov-Dec.
Erratum in
- Public Health Rep. 2008 Jan-Feb;123(1):table of contents. Oliveiria, Lucia [corrected to Oliveira, Lucia]
No abstract available
Similar articles
-
Descriptive analysis of immunization policy decision making in the Americas.Rev Panam Salud Publica. 2009 Nov;26(5):398-404. doi: 10.1590/s1020-49892009001100003. Rev Panam Salud Publica. 2009. PMID: 20107690
-
Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: lessons learned by PAHO's ProVac Initiative.Vaccine. 2011 Jan 29;29(5):1099-106. doi: 10.1016/j.vaccine.2010.11.075. Epub 2010 Dec 7. Vaccine. 2011. PMID: 21144916 Review.
-
Expansion of seasonal influenza vaccination in the Americas.BMC Public Health. 2009 Sep 24;9:361. doi: 10.1186/1471-2458-9-361. BMC Public Health. 2009. PMID: 19778430 Free PMC article.
-
PAHO'S Strategy for Universal Access to Health and Universal Health Coverage: implications for health services and hospitals in LAC.World Hosp Health Serv. 2015;51(2):4-6. World Hosp Health Serv. 2015. PMID: 26521377
-
[Exciting progress in the field of infection medicine. Several breakthroughs are to be expected during the next decade].Lakartidningen. 1999 Dec 1;96(48):5371-3. Lakartidningen. 1999. PMID: 10612988 Review. Swedish. No abstract available.
Cited by
-
Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal.BMC Med. 2011 May 12;9:55. doi: 10.1186/1741-7015-9-55. BMC Med. 2011. PMID: 21569407 Free PMC article.
-
Introducing a dengue vaccine to Mexico: development of a system for evidence-based public policy recommendations.PLoS Negl Trop Dis. 2014 Jul 31;8(7):e3009. doi: 10.1371/journal.pntd.0003009. eCollection 2014. PLoS Negl Trop Dis. 2014. PMID: 25077478 Free PMC article. Review. No abstract available.
-
Improved calibration estimators for the total cost of health programs and application to immunization in Brazil.PLoS One. 2019 Mar 6;14(3):e0212401. doi: 10.1371/journal.pone.0212401. eCollection 2019. PLoS One. 2019. PMID: 30840645 Free PMC article.
-
Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models.BMC Med. 2011 May 12;9:54. doi: 10.1186/1741-7015-9-54. BMC Med. 2011. PMID: 21569406 Free PMC article.
-
Adoption of new health products in low and middle income settings: how product development partnerships can support country decision making.Health Res Policy Syst. 2011 Mar 31;9:15. doi: 10.1186/1478-4505-9-15. Health Res Policy Syst. 2011. PMID: 21453529 Free PMC article.
References
-
- Pan American Health Organization. Estimating vaccine-preventable child mortality in the Americas. Immunization Newsletter. 2006;28:5–6.
-
- Garcia S, Levine OS, Cherian T, Gebastou JM, Andrus J. Working Group Members. Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction. Rev Panam Salud Publica. 2006;19:340–8. - PubMed
-
- Ferlay J, Bray F, Pisani P, Parkin DM. IARC CancerBase no. 5, version 2.0. Lyon (France): IARC Press; 2004. Globocan 2002: cancer incidence, mortality, and prevalence worldwide.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
